RSS Feed

  • New Study Finds Omega-3 Fatty Acid Supplements Ineffective in Treating Dry Eye Disease

    April 13, 2018
    More than 16 million Americans suffer from dry eye, an often chronic condition that causes burning, itching, or stinging sensations in the eye, as well as impaired vision. For years, patients and their eye doctors have turned to omega-3 fatty acids commonly found in fish-derived supplements as a treatment for the disease. Findings from a new randomized clinical trial, now show omega-3 supplements are no more effective than placebo at alleviating dry eye symptoms.
  • Three Solutions to Maximize the Clinical Benefit and Affordability of Targeted Cancer Drugs

    April 13, 2018
    Spending on cancer drugs in the United States has nearly doubled in the past five years and continues to grow, imposing substantial financial burden on patients with cancer. One of the biggest drivers of this growth is targeted cancer drugs – small molecules, monoclonal antibodies, and other therapies for cancer that target specific genomic aberrations.
  • Penn Medicine at the 2018 American Association for Cancer Research Annual Meeting

    April 13, 2018

    Experts from the Perelman School of Medicine at the University of Pennsylvania will be presenting data on the latest advances in cancer research and treatment at AACR's Annual Meeting in Chicago from April 14-18. Watch this space for press releases as embargoes lift during the meeting.

  • Heart Failure, COPD, Transitional Care Models, and Telemedicine Take Center Stage at Penn Medicine’s Innovation Accelerator Pitch Day

    April 12, 2018
    Approximately 20 percent of patients admitted to the hospital with chronic obstructive pulmonary disease (COPD) are readmitted within 30 days, and it’s estimated that 10 to 50 percent of these return trips may be preventable. In just 90 days, a multidisciplinary team from Penn Medicine has shown that an automated texting program to monitor COPD patient status following discharge may have helped prevent three readmissions and intervened with one life-saving hospitalization. 
  • Personalized Tumor Vaccine Shows Promise in Pilot Trial

    April 11, 2018
    A new type of cancer vaccine has yielded promising results in an initial clinical trial conducted at the Perelman School of Medicine at the University of Pennsylvania and the Abramson Cancer Center of the University of Pennsylvania. The personalized vaccine is made from patients’ own immune cells, which are exposed in the laboratory to the contents of the patients’ tumor cells, and then injected into the patients to initiate a wider immune response.
  • Most Widely Prescribed Diabetes Drug Improves Nicotine Withdrawal Symptoms in Animal Model

    April 11, 2018
    Metformin, the most widely used medication for diabetes, has also been shown to help treat dementia and some cancers. New research from the Perelman School of Medicine at the University of Pennsylvania and Johns Hopkins Medicine shows smoking cessation may be added to that list.
  • Cancer Risk Rises as Patients Wait for Diagnostic Testing

    April 10, 2018
    The longer a patient with a positive screening result waits for diagnostic testing, the worse their cancer outcomes may become, according to a literature review of breast, cervical, colorectal, and lung studies in the journal CA led by researchers at the Perelman School of Medicine at the University of Pennsylvania.
  • Screenshot

    Penn Medicine Receives Digital Innovation Award for First of its Kind Mobile App for Bariatric Surgery Patients

    April 10, 2018
    Penn Medicine received the Enterprise Award for Digital Innovation, given to an organization that applies new or existing technology in an innovative way to solve a problem or advance goals, from Philadelphia Alliance for Capital and Technologies (PACT) for the creation of Penn Life Gained, a first-of-its-kind mobile app for bariatric surgery patients.
  • Robert H. Vonderheide

    The “Immuno Revolution”: Turning Up the Heat on Resistant Tumors

    April 10, 2018
    A promising class of drugs known as CD40 monoclonal antibodies could be the spark needed to light the fire in the immune system of patients who don’t respond to the newer cancer immunotherapies.
  • Penn Radiology Researcher James Gee Inducted into Medical and Biological Engineering Elite

    April 10, 2018
    James C. Gee, PhD, an associate professor of Radiologic Science and director of the Penn Image Computing and Science Laboratory in the department of Radiology at the Perelman School of Medicine at the University of Pennsylvania, has been inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.